Quintiles

Expression Analysis, Illumina launch 2014 grant program

Monday, August 25, 2014 02:13 PM

Expression Analysis (EA), a Quintiles company based in Research Triangle Park, N.C., is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research.

More... »

WIRB Copernicus Group

Ventana, Quintiles ink agreement for companion diagnostic services in China

Thursday, August 7, 2014 10:00 AM

Ventana Medical Systems, a member of the Roche Group, has inked a new agreement with Quintiles to offer College of American Pathology (CAP) standard companion diagnostic testing services in China for pharmaceutical and biotech companies conducting early phase clinical trials. China is one of the only countries in the world that requires all patient samples be tested in China, even those used in clinical trials.

More... »


HeartWare International appoints Katrin Leadley chief medical officer

Monday, August 4, 2014 03:48 PM

HeartWare International, an innovator of less invasive, miniaturized circulatory support technologies for advanced heart failure, has appointed Katrin Leadley, M.D., as chief medical officer of HeartWare, effective September 1. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience at life sciences firms, including QuintilesBoston Scientific and JenaValve Technology in Munich, where she spent the last three years as chief medical officer leading the company's clinical, regulatory, scientific and medical activities.

More... »

Quintiles, Modern Marketing Concepts launch marketing analytics platform

Monday, June 23, 2014 03:46 PM

Quintiles and Modern Marketing Concepts (MMC) have launched a new marketing analytics platform that enables Quintiles to optimize sales and marketing efforts on behalf of its U.S. commercialization customers. Quintiles and MMC combine proprietary channel preference data with the innovative Next Action Marketing platform to create optimized physician communication strategies that align with their preferences and behaviors.

More... »

DrugDev establishes DrugDev Innovation Lab, partners with two technology firms

Thursday, June 12, 2014 01:43 PM

DrugDev, a provider of technology-driven solutions that help investigators, sponsors and CROs conduct more trials together, has established the DrugDev Innovation Lab, a technology incubator designed to accelerate emerging solutions in clinical trial automation.

More... »

Quintiles, American Physical Therapy Association develop outcomes registry

Wednesday, June 11, 2014 12:52 PM

Quintiles and the American Physical Therapy Association (APTA) have formed a new strategic collaboration to develop and implement the Physical Therapy Outcomes Registry, intended to be the largest and most comprehensive physical therapy electronic repository to date.

More... »

BioDelivery Sciences receives FDA approval for BUNAVAIL for opioid dependence

Monday, June 9, 2014 10:24 AM

BioDelivery Sciences International has received approval of the NDA for BUNAVAIL (buprenorphine and naloxone) buccal film (CIII) from the FDA. BUNAVAIL is indicated for the maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. BDSI expects to launch BUNAVAIL late in the third quarter of 2014.

More... »

Quintiles named to 2014 CIO 100

Friday, June 6, 2014 01:53 PM

Quintiles has been named to the 2014 CIO 100. Each year, CIO magazine identifies and honors 100 organizations that have distinguished themselves by creating business value through the effective and innovative use of IT.

More... »

Quintiles to acquire Encore Health Resources

Monday, May 12, 2014 12:49 PM

Quintiles has announced it will acquire Encore Health Resources, a company in the health-information analytics and technology services industry focused on healthcare providers. 

More... »

Japan’s CRO market growing as sponsors increase outsourcing to preferred vendors

Monday, April 28, 2014 02:33 PM

Four large CROs—two in Japan and two based in the U.S.—are leading a $213 billion Japanese CRO market that has grown in the past decade as the country’s pharmaceutical companies, which traditionally have performed its clinical trials services in-house, have followed the path of U.S. sponsors in choosing full-service CROs as preferred vendors.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs